article thumbnail

New ACC Scientific Statement Addresses Management of Obesity in HF

American College of Cardiology

A new ACC Scientific Statement addresses the management of obesity in adults with heart failure (HF), with a specific focus on those with stage 2 HF with preserved ejection fraction (HFpEF).

article thumbnail

Overweight and Obesity — Capturing the Whole Picture

The New England Journal of Medicine

Overweight and obesity represent addressable proximal drivers of chronic disease.1 1 The prevalence of overweight and obesity is increasing around the world; by 2050, projections indicate that more than half the adult population worldwide will be living with overweight and obesity, most prominently in China (an estimated 627 million.

Obesity 69
article thumbnail

CVD and obesity: When protective lipids decline, health risks increase

Science Daily - Heart Disease

New research has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes -- not the presence of certain fats, but their suppression. Ironically, the findings could ultimately lead to therapies that maintain high levels of these protective lipids in patients with obesity.

Obesity 66
article thumbnail

The Future of Obesity Treatment with Martha Gulati, MD

HCPLive

Gulati covers the promises and pitfalls of the healthcare world’s increasing focus on obesity as a disease and the variety of complications to which it gives rise.

Obesity 59
article thumbnail

Using AI to Explore CPAP’s Impact on Abdominal Obesity in OSA, with Jennifer Prevot, MD

HCPLive

Prevot describes her research exploring the relationship between OSA severity and abdominal obesity metrics as well as changes in both metrics following CPAP.

Obesity 64
article thumbnail

Classifying Obesity as a Chronic Disease with W. Timothy Garvey, MD

HCPLive

Timothy Garvey, MD Fact checked by: Ryan Livingston Conference | Heart in Diabetes The recent Lancet Commission on Obesity has repositioned the former risk factor as a disease, indicating and emphasizing a variety of complications. Garvey also spoke on the Commission’s development of a separate category of obesity-related diseases.

Obesity 52
article thumbnail

Dual Agonists and Upstream Obesity Treatment with Kausik Ray, FMedSci

HCPLive

By targeting insulin resistance at its source, dual receptor agonists may have a more efficient method of tackling the growing obesity problem, as well as its cardiovascular effects.

Obesity 59